Trade name
Vimpat
Strength
10 mg/mL (volume: 20 mL)
IV administration
Give undiluted or dilute to a convenient volume and give over 30 minutes to 1 hour.
Other routes of administration
IM: Not recommended.
SC: Not recommended.
Compatible IV fluids
Glucose 5%
Hartmann’s
Sodium chloride 0.9%
Additional information
Extravasation risk.
Rapid administration may cause CNS effects including dizziness, somnolence and paraesthesia.
Monitor heart rate and blood pressure during administration.
Use with caution in patients with cardiac conditions, and in those who are predisposed to PR interval prolongation or being administered other medications known to prolong the PR interval. These patients require ECG monitoring before administration and when at steady state.
Taper the infusion slowly when discontinuing treatment; abrupt discontinuation may cause increased seizure frequency.
Discard any unused vial contents.